Who Paid My Doc
Duc Vo
Colon & Rectal Surgery Springfield, OR Medical Doctor
NPI 1770564015 CMS profile 216167
3355 Riverbend Dr Ste 300, Springfield, OR 97477
General payments
$8,311
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Duc Vo of Springfield, OR is reported in the CMS Open Payments database as having received $8,311 across 138 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 73rd percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $66 | 1 | |
| 2023 | General | $170 | 10 | |
| 2022 | General | $590 | 18 | |
| 2021 | General | $412 | 23 | |
| 2020 | General | $2,558 | 36 | |
| 2019 | General | $4,515 | 50 |
Beside peers
- Duc Vo
- Colon & Rectal Surgery median
- Middle half of Colon & Rectal Surgery
- National median
In program year 2025, general payments to Duc Vo were reported at $66. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.
Show as a table
| Year | Duc Vo | Colon & Rectal Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $4,515 | $443 | $125–$2,179 | $163 |
| 2020 | $2,558 | $167 | $53–$931 | $114 |
| 2021 | $412 | $207 | $72–$1,272 | $132 |
| 2022 | $590 | $341 | $111–$1,587 | $149 |
| 2023 | $170 | $322 | $115–$1,420 | $160 |
| 2024 | $0 | $328 | $112–$1,354 | $164 |
| 2025 | $66 | $317 | $109–$1,248 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 14 billing codesPaid by Medicare
$8,843
Medicare patients
18
Services billed
176
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
138 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Colon & Rectal Surgery in Oregon
Khayree Butler
Colon & Rectal Surgery · Portland, OR
Douglas Khoury
Colon & Rectal Surgery · Portland, OR
Paul Kaminsky
Colon & Rectal Surgery · Portland, OR
Sungeyun Cho
Colon & Rectal Surgery · Clackamas, OR
Michael Doorly
Colon & Rectal Surgery · Hillsboro, OR
Daniel Herzig
Colon & Rectal Surgery · Portland, OR
Related records
Colon & Rectal Surgery in Oregon
Practitioners in the same specialty and state, ranked by reported value.
All Colon & Rectal Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Oregon
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.